6533b82cfe1ef96bd128ec9f
RESEARCH PRODUCT
Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes.
Jörg W. WegenerHermann Nawrathsubject
DevapamilGallopamilPatch-Clamp TechniquesHeart Ventricleschemistry.chemical_elementPharmacologyCalciumRats Sprague-Dawleychemistry.chemical_compoundmedicineExtracellularAnimalsPatch clampGallopamilPharmacologyBinding SitesChemistryCalcium channelCell MembraneGeneral MedicineCalcium Channel BlockersRatsVerapamilcardiovascular systemVerapamilCalcium ChannelsIntracellularmedicine.drugdescription
The effects of the phenylalkylamines verapamil, gallopamil, and devapamil on L-type calcium currents (ICa) were studied in ventricular myocytes from rat hearts using the whole-cell patch-clamp technique. In particular, the question was addressed, whether the pharmacological binding sites for these drugs were located at the inner and/or at the outer surface of the cell membrane. Therefore, tertiary verapamil, gallopamil, and devapamil and their corresponding quaternary derivatives were applied either from the outside or the inside of the cell membrane. Extracellular application of verapamil, gallopamil and devapamil (each at 3 microM) reduced ICa to 16.1 +/- 8.6%, 11 +/- 8.9%, and 9.3 +/- 6% of control, respectively. Intracellular application of the same substances, via the patch pipette filled with 30 microM of either verapamil, gallopamil, or devapamil, failed to depress ICa. The quaternary derivatives of the phenylalkylamines (30 microM) were ineffective both when applied extracellularly or intracellularly. It is suggested that phenylalkylamines block ICa in ventricular myocytes by acting on a binding site of the calcium channel molecule located at the outer surface of the cell membrane.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1995-09-01 | Naunyn-Schmiedeberg's archives of pharmacology |